Status:

COMPLETED

Functional Interval Training for Veterans Exercising Through Telehealth.

Lead Sponsor:

VA Office of Research and Development

Collaborating Sponsors:

Atlanta VA Medical Center

Baltimore VA Medical Center

Conditions:

HIV Infection

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

Most Veterans living with HIV are 50 years of age or older and can expect to live more than 20 years longer with HIV medication. However, despite this success, Veterans living with HIV are more likely...

Detailed Description

The Veterans Health Administration (VHA) is the largest U.S. HIV health provider with 64% of these Veterans 50+ years of age. HIV infection in the setting of antiretroviral therapy represents a chroni...

Eligibility Criteria

Inclusion

  • Veteran living with HIV and under care at VAMC
  • 50 years of age and older
  • Stable antiretroviral therapy (same ARV medications within 3 months)
  • At least one HIV-1 PCR \< 20 c/ml (viral load) within prior 6 months

Exclusion

  • History of AIDS defining illnesses (within 6 months; CDC Criteria)
  • Myocardial infarction (within 3 months)
  • Exertional or unstable angina (current chest pain that limits activity)
  • Severe congestive heart failure (EF \< 20% in last year or NYHA Classification III or IV)
  • Uncontrolled hypertension (SBP \>180 \&/or DBP \> 110 mm Hg)
  • Therapy with beta blockers or non-dihydropyridine calcium channel blocker (within 1 month)
  • Screening EKG with ischemia, complex arrhythmia, or high-grade block (per Minnesota Code)
  • Poorly controlled DM within prior 1 month (FBS\>180 mg/dl, RBS \> 299 mg/dl, or HbA1C \> 10)
  • Receiving treatment for cancer except skin cancer (within 3 months)
  • Peripheral vascular disease with claudication
  • Severe arthritis limiting ambulation
  • Neurologic disease limiting ambulation (requiring assist device)
  • End stage liver disease (decompensated liver disease)
  • Chronic renal failure (requiring dialysis)
  • Severe pulmonary disease (home O2, admission for dyspnea or pneumonia within 1 month)
  • Use of systemic steroids (testosterone or glucocorticoids) or growth hormone (within 6 months)
  • Dementia (based on Evaluation to Consent)
  • Signs or symptoms of any medical comorbidity that would preclude exercise testing or training
  • Exercise on routine basis (structured aerobic exercise \> 3 times per week) within 1 month
  • Past medical history of COPD or emphysema AND mMRC score =4

Key Trial Info

Start Date :

March 10 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 27 2024

Estimated Enrollment :

89 Patients enrolled

Trial Details

Trial ID

NCT04103593

Start Date

March 10 2020

End Date

September 27 2024

Last Update

January 7 2026

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, United States, 30033

2

Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Baltimore, Maryland, United States, 21201

3

Salem VA Medical Center, Salem, VA

Salem, Virginia, United States, 24153-6404